Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

Panelists discuss potential changes to clinical pathways for Bruton tyrosine kinase (BTK) inhibitor therapies as a result of ...

Panelists discuss the specific challenges and barriers clinicians might encounter when utilizing different BTK inhibitors ...

With the approval of the FDA, garadacimab can help patients with hereditary angioedema (HAE) prevent attacks by shutting down the contact pathway.

As clinician shortages grow, hospitals turn to artificial intelligence (AI) and scheduling tools to optimize resources, ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

Pediatric patients with hidradenitis suppurativa have a significantly increased prevalence of chronic medical and psychiatric ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

A panelist discusses the latest advancements presented at ASCO 2025, highlighting talquetamab’s pivotal trial in relapsed/refractory multiple myeloma that demonstrated high response rates and longer ...

B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City, reflects on how the reality of COVID-19 infection proved far more complex than ...